Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Expects Quintuple Diabetes, Quadruple Dementia Cases

This article was originally published in PharmAsia News

Executive Summary

An expected rise in obesity levels in Australia is seen as leading to a tripling in health care spending over the next 25 years to deal with diabetes and dementia, a report says. The Australian Institute of Health and Welfare forecast a quintupling of diabetes cases during the period and a quadrupling of spending on dementia cases. The author of the report said diabetes in Australia already is bad and the forecast of spending increases assumes the current growth rate of obesity will continue. The growth in dementia cases is based on projections of a tripling of the number of Australians over the age of 65 by 2050. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel